Cargando…

Extracellular Matrix–Related Six-lncRNA Signature as a Novel Prognostic Biomarker for Bladder Cancer

INTRODUCTION: Bladder cancer (BC) is the fourth-commones cancer and the sixth-leading cause of cancer-related death among men. However, a lack of reliable biomarkers remains a problem forprognosis and treatment of BC. lncRNAs have been shown to play important roles in various cancers, and have emerg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qing, Liangliang, Gu, Peng, Liu, Mingsheng, Shen, Jihong, Liu, Xiaodong, Guang, Runyun, Ke, Kunbin, Huang, Zhuo, Lee, Wenhui, Zhao, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733340/ https://www.ncbi.nlm.nih.gov/pubmed/33324071 http://dx.doi.org/10.2147/OTT.S284167

Ejemplares similares

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020)

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021)

A pyroptosis‐related lncRNA signature in bladder cancer
por: Wang, Peng, et al.
Publicado: (2022)

Construction of an immune‐related LncRNA signature with prognostic significance for bladder cancer
por: Luo, Wen‐Jie, et al.
Publicado: (2021)

Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
por: Yang, Kai, et al.
Publicado: (2017)

Identification of a six-lncRNA signature based on a competing endogenous RNA network for predicting the risk of tumour recurrence in bladder cancer patients
por: Zhao, Danfeng, et al.
Publicado: (2020)

Erratum: Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
por: Yang, Kai, et al.
Publicado: (2017)

Identification of a Six-lncRNA Signature With Prognostic Value for Breast Cancer Patients
por: Zhao, Erjie, et al.
Publicado: (2020)

Development of six immune‐related lncRNA signature prognostic model for smoking‐positive lung adenocarcinoma
por: Zhou, Dajie, et al.
Publicado: (2022)

The Prognostic Significance of Metabolic Syndrome and a Related Six-lncRNA Signature in Esophageal Squamous Cell Carcinoma
por: Liu, Yu, et al.
Publicado: (2020)

Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer
por: Zhao, Kai, et al.
Publicado: (2021)

Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer
por: Hua, Shan, et al.
Publicado: (2021)

A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer
por: Yu, Zuhu, et al.
Publicado: (2022)

Identification of pyroptosis-related lncRNA subtype and signature predicts the prognosis in bladder cancer
por: Zeng, Tao, et al.
Publicado: (2023)

A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
por: Bai, Yuchen, et al.
Publicado: (2022)

Identification and validation of a twelve immune infiltration-related lncRNA prognostic signature for bladder cancer
por: Liu, Chen-Qian, et al.
Publicado: (2022)

Alterations of mRNA and lncRNA profiles associated with the extracellular matrix and spermatogenesis in goats
por: Chen, Haolin, et al.
Publicado: (2022)

Development of a Ferroptosis-Related lncRNA Signature to Predict the Prognosis and Immune Landscape of Bladder Cancer
por: Zhou, Ranran, et al.
Publicado: (2021)

Genomewide identification of a novel six‐LncRNA signature to improve prognosis prediction in resectable hepatocellular carcinoma
por: Wu, Ying, et al.
Publicado: (2018)

Construction of the Six-lncRNA Prognosis Signature as a Novel Biomarker in Esophageal Squamous Cell Carcinoma
por: Zheng, Ze-Jun, et al.
Publicado: (2022)

A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma
por: Bao, Zhenyu, et al.
Publicado: (2017)

Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Lianghao, et al.
Publicado: (2021)

A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients
por: Chen, Mei, et al.
Publicado: (2021)

The LncRNA Connectivity Map: Using LncRNA Signatures to Connect Small Molecules, LncRNAs, and Diseases
por: Yang, Haixiu, et al.
Publicado: (2017)

A neutrophil extracellular traps-associated lncRNA signature predicts the clinical outcomes in patients with lung adenocarcinoma
por: Ding, Wencong, et al.
Publicado: (2022)

lncRNA expression signatures in response to enterovirus 71 infection
por: Yin, Zhixin, et al.
Publicado: (2013)

A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

A five necroptosis-related lncRNA signature predicts the prognosis of bladder cancer and identifies hot or cold tumors
por: Li, Han, et al.
Publicado: (2023)

A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis
por: Bian, Chengyu, et al.
Publicado: (2022)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022)

lncRNA-disease association prediction based on matrix decomposition of elastic network and collaborative filtering
por: Wang, Bo, et al.
Publicado: (2022)

Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1
por: Shen, Junlin, et al.
Publicado: (2023)

Constructing an immune‐ and ferroptosis‐related lncRNA signature to predict the immune landscape of human bladder cancer
por: Li, Xing, et al.
Publicado: (2022)

Construction and validation of cuproptosis-related lncRNA prediction signature for bladder cancer and immune infiltration analysis
por: Li, Hanrong, et al.
Publicado: (2023)

A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer
por: Cai, Jinming, et al.
Publicado: (2023)

Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma
por: Liu, Binfeng, et al.
Publicado: (2022)

Differential Expression of LncRNA in Bladder Cancer Development
por: Spirito, Lorenzo, et al.
Publicado: (2023)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

A four-lncRNA risk signature for prognostic prediction of osteosarcoma
por: Liu, Huanlong, et al.
Publicado: (2023)

A Necroptosis-Related lncRNA to Develop a Signature to Predict the Outcome, Immune Landscape, and Chemotherapeutic Responses in Bladder Urothelial Carcinoma
por: Hou, Jian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6oh0poonk7dletlb4dtojj5fh8